Article de revue

Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts

Td (reduced diphtheria toxoid, ≥2–5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization programs in many low- and middle-income countries. For this reason, WHO convened an expert consultation to review the currently available evidence for the use of Td vaccine from 4 to 7 years of age.

Langues

  • Anglais

Année de publication

2020

Journal

Vaccine

Volume

21

Type

Article de revue

Catégories

  • Gestion de programme

Maladies

  • Tétanos

Organisations

  • Organisation Mondiale de la Santé (OMS)

Références sur le sujet

EPI-CORE-TETANUS

TitreAuteurAnnéeTypeLangue
Protecting All Against Tetanus: Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populationsWorld Health Organization (WHO)2019GuidanceAnglais
Replacement of TT with Td vaccine – July 2018UNICEF, World Health Organization (WHO)2018GuidanceFrançais
Tetanus serosurvey guidanceWorld Health Organization (WHO)2018GuidanceAnglais
Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of expertsHeather M. Scobie, S. Desai, Thomas Cherian, Tracey Goodman2020Journal articleAnglais
Validation of Maternal and Neonatal Tetanus EliminationWorld Health Organization (WHO)2014GuidanceAnglais, Français